Pharma Stability: Insights, Guidelines, and Expertise
Temperature and humidity are the two most critical environmental variables in stability studies. Elevated levels accelerate chemical reactions, hydrolysis, oxidation, and physical changes in pharmaceutical products. ICH Q1A(R2) defines standard conditions for accelerated testing as 40°C ± 2°C and 75% RH ± 5% RH.
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
This case involves a fixed-dose combination (FDC) of two antihypertensive agents in film-coated tablet form. The product was intended for global submission, including regions in Climatic Zones II, III, and IVb. The project aimed to establish a shelf life of 24 months using real-time data compliant with ICH Q1A(R2).
Click to read the full article.
Testing a single batch may not capture variability in the manufacturing process, formulation, or container-closure system. Regulatory authorities expect multi-batch data to assess:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
The International Council for Harmonisation (ICH) classifies the world into climatic zones based on average temperature and relative humidity. This classification standardizes stability testing requirements for global drug registration.
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.
Excipients serve multiple functions in pharmaceutical dosage forms, including bulking, coating, disintegration, and preservation. Their chemical and physical properties can interact with APIs and affect degradation pathways under long-term storage conditions.
Click to read the full article.
Pharmaceutical development is often time-constrained. Predictive shelf life modeling enables manufacturers to:
Click to read the full article.
Available from Pharma SOP:
Click to read the full article.